A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Contraception
Interventions
DRUG

Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets

1 tablet daily

Trial Locations (11)

14609

Duramed Investigational Site, Rochester

20006

Duramed Investigational Site, Washington D.C.

22203

Duramed Investigational Site, Arlington

23507

Duramed Investigational Site, Norfolk

27103

Duramed Investigational Site, Winston-Salem

28209

Duramed Investigational Site, Charlotte

37203

Duramed Investigational Site, Nashville

43213

Duramed Investigational Site, Columbus

68510

Duramed Investigational Site, Lincoln

73112

Duramed Investigational Site, Oklahoma City

85715

Duramed Investigational Site, Tucson

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duramed Research

INDUSTRY